Get the Stockscreener App
7.18
2.72%
0.19
Pre-market:
7.18
Neuraxis Inc stock is traded at $7.18, with a volume of 145.19K.
It is up +2.72% in the last 24 hours and up +4.66% over the past month.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
See More
Previous Close:
$6.99
Open:
$7
24h Volume:
145.19K
Relative Volume:
0.97
Market Cap:
$80.33M
Revenue:
$3.57M
Net Income/Loss:
$-7.80M
P/E Ratio:
-7.3998
EPS:
-0.9703
Net Cash Flow:
$-6.56M
1W Performance:
-2.18%
1M Performance:
+4.66%
6M Performance:
+136.96%
1Y Performance:
+315.03%
1-Day Range:
$6.95
$7.40
1-Week Range:
$6.7217
$7.60
52-Week Range:
$1.33
$7.97
Neuraxis Inc Stock (NRXS) Company Profile
Name
Neuraxis Inc
Sector
Industry
Phone
(812) 689-0791
Address
11550 North Meridian Street, Suite 325, Carmel
Compare NRXS vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
7.18 | 76.52M | 3.57M | -7.80M | -6.56M | -0.9703 |
VRTX
Vertex Pharmaceuticals Inc
|
444.28 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
755.51 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
828.35 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
339.41 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
310.00 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Neuraxis Inc Stock (NRXS) Latest News
Moving Averages: Is NeurAxis Inc a strong growth stock2026 Trading Recap & Verified Entry Point Signals - baoquankhu1.vn
Meme Stocks: Is NeurAxis Inc likely to announce a buybackWeekly Market Summary & Real-Time Stock Entry Alerts - baoquankhu1.vn
Support Test: Will NeurAxis Inc stock hit new highs in YEAR2026 Earnings Surprises & Low Risk High Win Rate Picks - baoquankhu1.vn
Targets Report: Whats next for NeurAxis Inc stockLong Setup & Daily Market Momentum Tracking - baoquankhu1.vn
Energy Moves: Is NeurAxis Inc impacted by rising ratesQuarterly Portfolio Summary & Risk Managed Trade Strategies - baoquankhu1.vn
NeurAxis, Inc. Declares Stock Dividend on Series B Preferred Stock - Quiver Quantitative
NeurAxis, Inc. Announces Preferred Stock Dividend - Caledonian Record
Technical Analysis: Can NeurAxis Inc reach all time highs this yearEarnings Beat & Community Shared Stock Ideas - baoquankhu1.vn
Big Picture: Does NeurAxis Inc meet Warren Buffetts criteriaWeekly Trend Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Winners Losers: Does NeurAxis Inc have pricing powerQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
NeurAxis (NASDAQ:NRXS) CFO Buys $14,882.28 in Stock - Defense World
NRXS PE Ratio & Valuation, Is NRXS Overvalued - Intellectia AI
Top NeurAxis Insiders Make Bold Moves With Fresh Stock Buys - TipRanks
Neuraxis CEO Carrico buys $15,797 in company stock By Investing.com - Investing.com Australia
Neuraxis CFO Henrichs buys $14,882 in company stock - Investing.com
Neuraxis Inc: CRO Carrico buys $1307 in shares By Investing.com - Investing.com India
Neuraxis CFO Henrichs buys $14,882 in company stock By Investing.com - Investing.com South Africa
Insider Buying: NeurAxis (NASDAQ:NRXS) CFO Buys 7,593 Shares of Stock - MarketBeat
Insider Buying: NeurAxis (NASDAQ:NRXS) CEO Buys 8,060 Shares of Stock - MarketBeat
Neuraxis CEO Carrico buys $15,797 in company stock - Investing.com
Neuraxis (NRXS) CFO acquires 7,593 shares at $1.96 in open trade - Stock Titan
Neuraxis (NRXS) executive makes small open-market share purchase - Stock Titan
Neuraxis (NRXS) CEO boosts stake with open-market buy of 8,060 shares - Stock Titan
Aug Final Week: Is NeurAxis Inc a speculative investmentVolume Spike & Real-Time Stock Movement Alerts - baoquankhu1.vn
New Highs: Can NeurAxis Inc expand its profit marginsQuarterly Investment Review & Real-Time Stock Entry Alerts - baoquankhu1.vn
Insider Trends: Does NeurAxis Inc have pricing power2026 Levels & Technical Confirmation Alerts - baoquankhu1.vn
Treasury Yields: Should I trade or invest in NeurAxis Inc2026 Pullbacks & Capital Efficiency Focused Ideas - baoquankhu1.vn
NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth - TradingView
NeurAxis Shares Rise After Q4 Results Driven by Robust Revenue Expansion - Bitget
If You Invested $1,000 in Neuraxis Inc (NRXS) - Stock Titan
Craig Hallum Increases NeurAxis (NASDAQ:NRXS) Price Target to $13.00 - Defense World
Dip Buying: Can NeurAxis Inc outperform under higher oil prices2026 Trading Recap & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Gainers Report: Can NeurAxis Inc expand its profit marginsEarnings Beat & AI Powered Market Entry Ideas - baoquankhu1.vn
Neuraxis, Inc.: Fundamental Analysis and Financial Ratings | NRXS | US64134X2018 - marketscreener.com
NeurAxis (NASDAQ:NRXS) Given New $13.00 Price Target at Craig Hallum - MarketBeat
NeurAxis revenue up 27% year to USD 968000 in Q4FY25 - Medical Buyer
NRXS Gains Momentum as Craig-Hallum Raises Price Target to $13.0 - GuruFocus
NeurAxis Earnings Call: Reimbursement Wins Drive Next Phase - TipRanks
Earnings call transcript: NeurAxis Q4 2025 sees revenue growth, stock dips - Investing.com Australia
NeurAxis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
NeurAxis, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
NRXS: FY2025 revenue rose 33% to $3.6M, with improved net loss and expanded market access - tradingview.com
NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results - Bluefield Daily Telegraph
Neuraxis 10-K: $3.57M Revenue, $(7.80)M Net Loss - TradingView
Neuraxis (NRXS) expands IB-Stim GI neuromodulation, RED constipation device and IP moat - Stock Titan
Levels Update: Should I trade or invest in NeurAxis Inc2026 Top Gainers & Expert Curated Trade Ideas - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Argenx Se (ARGX) and Teladoc (TDOC) - The Globe and Mail
Aug Ideas: What is the implied volatility of NeurAxis Inc2026 Fed Impact & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
NeurAxis, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
NeurAxis, Inc. Hits New 52-Week High of $7.46, Up 141.44% - Markets Mojo
Neuraxis Inc Stock (NRXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.81%
Cap:
|
Volume (24h):